Search
    Skip to main content
    Advertisement

    Bayer

    1. Business
    2. Pharmaceuticals
    3. Bayer
    Stat Plus: Bayer sues J&J over ‘false and misleading claims’ about competing prostate cancer… STAT14:51Prostate Cancer Cancer Treatment Johnson & Johnson
    Bayer prostrate cancer medicine Nubeqa approved for expanded use in non-chemotherapy patients The Hindu Business Line02:00India Pharma
    Bayer’s Xofigo plus Xtandi extends Os in mCRPC with bone metastases Clinical Trials Arena11:51Prostate Cancer Pharma
    Bayer Q4 earnings match estimates, xarelto and eylea pull down sales Zacks12:12Pharma
    'India has intellectual power to be a leader in biomedical innovation,' says Bayer AG The Times of India14:49India Pharma Biotech
    Bayer advances roundup settlement with Missouri court approval Zacks13:54Pharma Missouri
    Boehringer gets FDA's second 'national priority' approval pharmaphorum07:07Lung Cancer Pharma FDA
    Oh right, scrubs is pretty good at this Vulture10:58Pharma TV
    Monsanto never cracked weed. 2026 Might open the door High Times11:55Pharma
    Your drug formulas, clinical trials, and manufacturing lines are under attack. Here’s how to fight back. Security Boulevard20:11Pharma FDA

    Latest News

    Yesterday
    'India has intellectual power to be a leader in biomedical innovation,' says Bayer AG The Times of India14:49 12-Mar-26
    Endometriosis Market Expected to Achieve Significant CAGR During the Forecast Period… PR Newswire (Press Release)10:36 12-Mar-26
    In the last 7 days
    Bayer AG's Monsanto Pays $1M For Misclassified PCB Docs Law36023:52 11-Mar-26
    In the last month
    Bayer Advances Roundup Settlement With Missouri Court Approval Zacks13:54 5-Mar-26
    Oh Right, Scrubs Is Pretty Good at This Vulture10:58 5-Mar-26
    Bayer Q4 Earnings Match Estimates, Xarelto and Eylea Pull Down Sales Zacks12:12 4-Mar-26
    Monsanto Never Cracked Weed. 2026 Might Open the Door High Times11:55 27-Feb-26
    Bayer’s Xofigo plus Xtandi extends OS in mCRPC with bone metastases Clinical Trials Arena11:51 27-Feb-26
    Boehringer gets FDA's second 'national priority' approval pharmaphorum07:07 27-Feb-26
    Your Drug Formulas, Clinical Trials, and Manufacturing Lines Are Under Attack. Here’s How to Fight Back. Security Boulevard20:11 26-Feb-26
    Bayer Accuses J&J of Misleading Ads for Its Prostate-Cancer Drug Bloomberg Law13:37 24-Feb-26
    Bayer prostrate cancer medicine Nubeqa approved for expanded use in non-chemotherapy patients The Hindu Business Line02:00 24-Feb-26
    Bayer Sues J&J Over Alleged False Cancer Drug Claims Law36022:21 23-Feb-26
    STAT Plus: Bayer sues J&J over ‘false and misleading claims’ about competing prostate cancer… STAT14:51 23-Feb-26
    Intrauterine Devices (IUDs): Access and Coverage in the U.S. The Henry J. Kaiser Family Foundation11:27 19-Feb-26
    Proposed $7.25B settlement to resolve weedkiller cancer lawsuits STAT08:09 18-Feb-26
    BREAKING: Bayer AG Unveils $7.3B Deal For Roundup Users Law36012:28 17-Feb-26
    Bayer Files Suit Against Trio of COVID-19 Vaccine Makers JD Supra15:51 13-Feb-26
    Emerging Trends in Personalised Medicine at PHARMAP 2026 pharmaphorum05:33 12-Feb-26
    view more headlines
    12 Mar 14:49

    Bayer News

    NewsNow aims to be the world's most accurate and comprehensive aggregator of Bayer news, covering the latest share price, company announcements, product trials, pharmaceuticals news and more from the best online publications. Every story from every site is brought to you automatically and continuously 24/7, within around 10 minutes of publication.
    Read more

    Pharmaceuticals Top Stories

    AI, talent and cross domain innovation are redefining biomanufacturing in Asia Pacific BioSpectrum Asia00:45
    Beyond Keytruda: The next generation of cancer therapies takes shape Proactive Investors (Australia)20:54
    From volatility to vitality: How 2025 reset the life sciences market and what’s next for 2026 JD Supra14:25
    Vima banks $100m in Series A to progress Parkinson’s drug Pharmaceutical Technology12:35
    STAT Plus: Cancer cells can ‘barf’ proteins onto their cell surface. That may create new… STAT14:06

    Business Top Stories

    The Strait of Hormuz is an 'Acute vulnerability' for global trade. Here's what you need to know. Investopedia06:56Energy Strait of Hormuz Middle East
    Stocks sink 1.5% as crude oil hits $100 a barrel NewsMax16:08Energy Strait of Hormuz Middle East
    Dollar General delivered strong Q4 earnings, but here's why the stock isn't taking off The Motley Fool16:32Dollar General
    Dollar General is hitting on all cylinders following strong Q4 Supermarket News14:21Dollar General
    Brandlive launches BrandTV™, the Enterprise Streaming Platform Every Company Needs MarTech Series06:55AI IT
    Leveraging Coso to mitigate AI risk: A step-by-step guide Compliance Week16:38AI IT
    Palantir stock isn't cheap, but it might still be a bargain The Motley Fool04:44Palantir Top Internet Brands
    Prediction: 2 AI stocks will be worth more than Palantir Technologies in 5 years The Motley Fool04:44Palantir Top Internet Brands
    Why Morgan Stanley stock sank by 4% today The Motley Fool20:05Morgan Stanley Stock Markets Markets
    DOL seeks to toss suit over advisory opinion on Morgan Stanley Bloomberg Law16:50Morgan Stanley Stock Markets Markets
    Publication filters

    Headline Density

    Sorry, no headlines or news topics were found. Please try different keywords.